TransMedics Group Inc (TMDX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$3.26B
EV to revenue ratio (TTM)
4.73
EV to ebitda
24.73
Financial Performance
Revenue (TTM)
$0.73B
Gross profit (TTM)
$0.43B
EBITDA
$0.12B
Profitability
Operating margin (TTM)
13.90%
Profit margin
19.90%
Return on assets (TTM)
4.39%
Return on equity (TTM)
31.90%
Per Share Metrics
Revenue per share (TTM)
$21.11
EPS
$3.67
Diluted EPS (TTM)
$3.67
Book value
$15.86
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
25.56
Trailing P/E
25.56
Forward P/E
37.74
PEG ratio
0.76
Price to sales ratio (TTM)
4.48
Price to book ratio (TTM)
5.56
Growth
Quarterly earnings growth (YoY)
41.10%
Quarterly revenue growth (YoY)
-29.80%
Analyst Sentiment
Strong buy
3
Buy
6
Hold
4
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.10